{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:35:33Z","timestamp":1785458133122,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10286-020-00764-4","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T11:03:18Z","timestamp":1611745398000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and neurohormonal characteristics in African Americans with neurogenic orthostatic hypotension"],"prefix":"10.1007","volume":"31","author":[{"given":"Richard J.","family":"Giza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-0233","authenticated-orcid":false,"given":"Maureen C.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1380-6017","authenticated-orcid":false,"given":"Amy C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7667-7083","authenticated-orcid":false,"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4518-6801","authenticated-orcid":false,"given":"Cyndya A.","family":"Shibao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"764_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMcp074189","volume":"358","author":"R Freeman","year":"2008","unstructured":"Freeman R (2008) Neurogenic orthostatic hypotension. N Engl J Med 358:615. https:\/\/doi.org\/10.1056\/NEJMcp074189","journal-title":"N Engl J Med"},{"key":"764_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10286-017-0437-3","volume":"27","author":"H Kaufmann","year":"2017","unstructured":"Kaufmann H, Palma JA (2017) Neurogenic orthostatic hypotension: the very basics. Clin Auton Res 27:39\u201343","journal-title":"Clin Auton Res"},{"key":"764_CR3","unstructured":"Ringer M, Lappin SL (2019) Orthostatic Hypotension - StatPearls - NCBI Bookshelf. In: Orthostatic Hypotens. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448192\/. (Accessed 17 May 2020)"},{"key":"764_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pharmthera.2011.05.009","volume":"134","author":"C Shibao","year":"2012","unstructured":"Shibao C, Okamoto L, Biaggioni I (2012) Pharmacotherapy of autonomic failure. Pharmacol Ther 134:279\u2013286","journal-title":"Pharmacol Ther"},{"key":"764_CR5","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s00415-012-6736-7","volume":"260","author":"M Metzler","year":"2013","unstructured":"Metzler M, Duerr S, Granata R et al (2013) Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management. J Neurol 260:2212\u20132219","journal-title":"J Neurol"},{"key":"764_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1177\/0898264313491427","volume":"25","author":"TE Fuller-Rowell","year":"2013","unstructured":"Fuller-Rowell TE, Williams DR, Love GD et al (2013) Race differences in age-trends of autonomic nervous system functioning. J Aging Health 25:839\u2013862. https:\/\/doi.org\/10.1177\/0898264313491427","journal-title":"J Aging Health"},{"key":"764_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/HYPERTENSIONAHA.112.195313","volume":"60","author":"Y Okada","year":"2012","unstructured":"Okada Y, Galbreath MM, Jarvis SS et al (2012) Elderly blacks have a blunted sympathetic neural responsiveness but greater pressor response to orthostasis than elderly whites. Hypertension 60:842\u2013848. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.195313","journal-title":"Hypertension"},{"key":"764_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.04225","volume":"64","author":"CE Ramirez","year":"2014","unstructured":"Ramirez CE, Okamoto LE, Arnold AC et al (2014) Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension 64:1235\u20131240. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04225","journal-title":"Hypertension"},{"key":"764_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-015-0307-9","author":"JE Celedonio","year":"1981","unstructured":"Celedonio JE, Arnold AC, Dupont WD et al (1981) Residual sympathetic tone is associated with reduced insulin sensitivity in patients with autonomic failure. Clin Auto Res. https:\/\/doi.org\/10.1007\/s10286-015-0307-9","journal-title":"Clin Auto Res"},{"key":"764_CR10","first-page":"86","volume":"1","author":"D Robertson","year":"1981","unstructured":"Robertson D, Baughman KI, Green B (1981) Clinical pharmacology; assessment of autonomic function. Clin Diagnostic Man House Off 1:86\u2013101","journal-title":"Clin Diagnostic Man House Off"},{"key":"764_CR11","first-page":"25","volume":"5","author":"R Mosqueda-Garcia","year":"1995","unstructured":"Mosqueda-Garcia R (1995) Evaluation of the autonomic nervous sytem. Disord Auton Nervouse Syst 5:25\u201329","journal-title":"Disord Auton Nervouse Syst"},{"key":"764_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/ana.410260410","volume":"26","author":"DS Goldstein","year":"1989","unstructured":"Goldstein DS, Polinsky RJ, Garty M et al (1989) Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 26:558\u2013563. https:\/\/doi.org\/10.1002\/ana.410260410","journal-title":"Ann Neurol"},{"key":"764_CR13","first-page":"847","volume":"93","author":"RJ Workman","year":"1979","unstructured":"Workman RJ, Sussman CR, Burkitt DW, Liddle GW (1979) Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects. J Lab Clin Med 93:847\u2013856","journal-title":"J Lab Clin Med"},{"key":"764_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"A Fanciulli","year":"2018","unstructured":"Fanciulli A, Jordan J, Biaggioni I et al (2018) Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res 28:355\u2013362","journal-title":"Clin Auton Res"},{"key":"764_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1124\/pr.115.012161","volume":"69","author":"I Biaggioni","year":"2017","unstructured":"Biaggioni I (2017) The pharmacology of autonomic failure: from hypotension to hypertension. Pharmacol Rev 69:53\u201362. https:\/\/doi.org\/10.1124\/pr.115.012161","journal-title":"Pharmacol Rev"},{"key":"764_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1210\/jcem.76.3.7680352","volume":"76","author":"I Biaggioni","year":"1993","unstructured":"Biaggioni I, Garcia F, Inagami T, Haile V (1993) Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metab 76:580\u2013586. https:\/\/doi.org\/10.1210\/jcem.76.3.7680352","journal-title":"J Clin Endocrinol Metab"},{"key":"764_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","volume":"2","author":"AC Arnold","year":"2013","unstructured":"Arnold AC, Okamoto LE, Gamboa A et al (2013) Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure hypertension. Hypertension 2:701\u2013706","journal-title":"Hypertension"},{"key":"764_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.jhh.1001127","volume":"15","author":"GA Sagnella","year":"2001","unstructured":"Sagnella GA (2001) Why is plasma renin activity lower in populations of African origin? J Hum Hypertens 15:17\u201325. https:\/\/doi.org\/10.1038\/sj.jhh.1001127","journal-title":"J Hum Hypertens"},{"key":"764_CR19","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1046\/j.1523-1755.1998.06716.x","volume":"54","author":"C Wagner","year":"1998","unstructured":"Wagner C, Jensen BL, Kramer BK, Kurtz A (1998) Control of the renal renin system by local factors. Kidney Internat 54:S78\u2013S83","journal-title":"Kidney Internat"},{"key":"764_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00004872-198502000-00009","volume":"3","author":"A Morganti","year":"1985","unstructured":"Morganti A, Sala C, Turolo L et al (1985) Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension. J Hypertens 3:55\u201361. https:\/\/doi.org\/10.1097\/00004872-198502000-00009","journal-title":"J Hypertens"},{"key":"764_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/01.HYP.37.3.845","volume":"37","author":"AH El-Gharbawy","year":"2001","unstructured":"El-Gharbawy AH, Nadig VS, Morley Kotchen J et al (2001) Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension 37:845\u2013850. https:\/\/doi.org\/10.1161\/01.HYP.37.3.845","journal-title":"Hypertension"},{"key":"764_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00467-012-2367-6","volume":"28","author":"DG Murro","year":"2013","unstructured":"Murro DG, Beavers M, Harshfield GA, Kapuku GK (2013) Aldosterone contributes to elevated left ventricular mass in black boys. Pediatr Nephrol 28:655\u2013660. https:\/\/doi.org\/10.1007\/s00467-012-2367-6","journal-title":"Pediatr Nephrol"},{"key":"764_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.HYP.23.2.179","volume":"23","author":"ND Fisher","year":"1994","unstructured":"Fisher ND, Gleason RE, Moore TJ et al (1994) Regulation of aldosterone secretion in hypertensive blacks. Hypertension 23:179\u2013184. https:\/\/doi.org\/10.1161\/01.HYP.23.2.179","journal-title":"Hypertension"},{"key":"764_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0895-7061(99)00168-5","volume":"13","author":"E Ripley","year":"2000","unstructured":"Ripley E, King K, Sica DA (2000) Racial differences in response to acute dosing with hydrochlorothiazide. Am J Hypertens 13:157\u2013164. https:\/\/doi.org\/10.1016\/S0895-7061(99)00168-5","journal-title":"Am J Hypertens"},{"key":"764_CR25","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.113.02989","volume":"63","author":"W Tu","year":"2014","unstructured":"Tu W, Eckert GJ, Hannon TS et al (2014) Racial differences in sensitivity of blood pressure to aldosterone. Hypertension 63:1212\u20131218. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02989","journal-title":"Hypertension"},{"key":"764_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.115.06617","volume":"67","author":"AC Arnold","year":"2016","unstructured":"Arnold AC, Okamoto LE, Gamboa A et al (2016) Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension 67:424\u2013429. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06617","journal-title":"Hypertension"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-020-00764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-020-00764-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-020-00764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T14:40:29Z","timestamp":1614264029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-020-00764-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1007\/s10286-020-00764-4","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"RJG and MCF have no competing interests to declare. CAS received grant support from the Office of Orphan Products Development, Food and Drug Administration, Grant #FD-R-04778\u201301-A3. CAS has received speaker honorarium from Lundbeck Pharmaceuticals and consulting honoraria from Lundbeck and Theravance Biopharma. CAS and ACA are members of the Board of the American Autonomic Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}